miR-155 expression was downregulated in CD8 + T cells of RRMS patients and was associated with the patients’ Expanded Disability Status Scale (EDSS), shedding light on the potential use of miR-155 in the diagnosis of MS (Elkhodiry et al., 2021). Here, CD8A is linked to myeloid sarcoma.